Increased Uptake of 68 Ga-DOTA-IBA in Multiple Subcutaneous Metastases of Prostate Cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 39354690.
- Also identified by DOI 10.1097/RLU.0000000000005462.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Subcutaneous metastases are rare in prostate cancer. Herein, we present a case of a 66-year-old man with prostate cancer, who underwent 68 Ga-labeled DOTA-ibandronic acid ( 68 Ga-DOTA-IBA) PET/CT to explore the possibility of 177 Lu-DOTA-IBA treatment. 68 Ga-DOTA-IBA PET/CT demonstrated intensely increased uptake in the multiple osteoblastic bone metastases. Unexpectedly, 68 Ga-DOTA-IBA uptake in multiple subcutaneous metastases was also noted.
Medical subject headings
- Prostatic Neoplasms
- Positron Emission Tomography Computed Tomography